Preparation, characterization, and substrate metabolism of gold-immobilized cytochrome P450 2C9
- PMID: 16802783
- PMCID: PMC2556980
- DOI: 10.1021/ja0608693
Preparation, characterization, and substrate metabolism of gold-immobilized cytochrome P450 2C9
Abstract
The cytochrome P450 enzymes represent an important class of heme-containing enzymes. There is considerable interest in immobilizing these enzymes on a surface so that interactions between a single enzyme and other species can be studied with respect to electron transfer, homodimer or heterodimer interactions, or for construction of biological-based chips for standardizing cytochrome P450 metabolism or for high-throughput screening of pharmaceutical agents. Previous studies have generally immobilized P450 enzymes in a matrix or on a surface. Here, we have attached CYP2C9 to gold substrates such that the resulting construct maintains the ability to bind and metabolize substrates in the presence of NADPH and cytochrome P450 reductase. The activity of these chips is directly dependent upon the linkers used to attach CYP2C9 and to the presence of key molecules in the active site during enzyme attachment. A novel method to detect substrate-enzyme binding, namely, superconducting quantum interference device (SQUID) magnetometry, was used to monitor the binding of substrates. Most significantly, conditions that allow measurable CYP2C9 metabolism to occur have been developed.
Figures


Similar articles
-
CYP2C9 protein interactions with cytochrome b(5): effects on the coupling of catalysis.Drug Metab Dispos. 2007 Jul;35(7):1174-81. doi: 10.1124/dmd.107.014910. Epub 2007 Apr 19. Drug Metab Dispos. 2007. PMID: 17446262 Free PMC article.
-
Assessment of arginine 97 and lysine 72 as determinants of substrate specificity in cytochrome P450 2C9 (CYP2C9).Drug Metab Dispos. 2004 Apr;32(4):431-6. doi: 10.1124/dmd.32.4.431. Drug Metab Dispos. 2004. PMID: 15039296
-
Dissociation Constants of Cytochrome P450 2C9/Cytochrome P450 Reductase Complexes in a Lipid Bilayer Membrane Depend on NADPH: A Single-Protein Tracking Study.J Am Chem Soc. 2017 Dec 13;139(49):17923-17934. doi: 10.1021/jacs.7b08750. Epub 2017 Dec 4. J Am Chem Soc. 2017. PMID: 29148818
-
New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part I.Curr Drug Metab. 2009 Dec;10(10):1075-126. doi: 10.2174/138920009790820129. Curr Drug Metab. 2009. PMID: 20167001 Review.
-
Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development.Curr Med Chem. 2009;16(27):3480-675. doi: 10.2174/092986709789057635. Epub 2009 Sep 1. Curr Med Chem. 2009. PMID: 19515014 Review.
Cited by
-
Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation.Expert Opin Drug Metab Toxicol. 2010 Feb;6(2):115-31. doi: 10.1517/17425250903431040. Expert Opin Drug Metab Toxicol. 2010. PMID: 20064075 Free PMC article. Review.
-
Nanoscale electron transport measurements of immobilized cytochrome P450 proteins.Nanotechnology. 2015 Apr 17;26(15):155102. doi: 10.1088/0957-4484/26/15/155102. Epub 2015 Mar 25. Nanotechnology. 2015. PMID: 25804257 Free PMC article.
-
The use of immobilized cytochrome P4502C9 in PMMA-based plug flow bioreactors for the production of drug metabolites.Appl Biochem Biotechnol. 2014 Feb;172(3):1293-306. doi: 10.1007/s12010-013-0537-z. Epub 2013 Oct 30. Appl Biochem Biotechnol. 2014. PMID: 24166101 Free PMC article.
-
Electrocatalytic drug metabolism by CYP2C9 bonded to a self-assembled monolayer-modified electrode.Drug Metab Dispos. 2009 Apr;37(4):892-9. doi: 10.1124/dmd.108.025452. Epub 2009 Jan 26. Drug Metab Dispos. 2009. PMID: 19171677 Free PMC article.
-
Immobilized Cytochrome P450 for Monitoring of P450-P450 Interactions and Metabolism.Drug Metab Dispos. 2016 May;44(5):741-9. doi: 10.1124/dmd.115.067637. Epub 2016 Mar 9. Drug Metab Dispos. 2016. PMID: 26961240 Free PMC article.
References
-
- Fantuzzi A, Fairhead M, Gilardi G. J Am Chem Soc. 2004;126:5040–5041. - PubMed
-
- Backes WL, Kelley RW. Pharmac Ther. 2004;98:221–233. - PubMed
-
- Johnson DL, Lewis BC, Elliot DJ, Miners JO, Martin LL. Biochem Pharmacol. 2005;69:1533–1541. - PubMed
-
- Udit AK, Hill MG, Bittner VG, Arnold FH, Gray HB. J Am Chem Soc. 2004;126:10218–10219. - PubMed
-
- Iwuoha EI, Kane S, Ania CO, Smyth MR, Ortiz de Montellano PR, Fuhr U. Electroanalysis. 2000;12:980–986.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources